Sep 11, 2026 08:01AM

Jul 7, 2026 08:03AM

Jun 30, 2026 08:01AM

May 18, 2026 06:46AM

Apr 21, 2026 08:02AM

Dec 3, 2025 09:15AM

Nov 14, 2025 04:23PM Allarity Therapeutics (ALLR) Misses Q3 EPS by 19c

Sep 25, 2025 05:22PM

Aug 18, 2025 04:50PM

Jul 28, 2025 01:59AM

Jul 7, 2025 08:01AM

Jun 30, 2025 08:03AM

Jun 11, 2025 04:07PM

Jun 4, 2025 08:04AM Allarity Therapeutics (ALLR) Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Actio

May 9, 2025 05:03PM

Apr 25, 2025 08:01AM

Mar 24, 2025 08:01AM

Mar 17, 2025 08:00AM

Mar 13, 2025 08:33AM

Mar 3, 2025 08:01AM

Feb 6, 2025 08:01AM Allarity Therapeutics (ALLR) Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 4, 2025 10:51AM

Jan 30, 2025 08:06AM

Nov 18, 2024 08:03AM

Oct 22, 2024 08:00AM

Oct 10, 2024 08:00AM

Sep 16, 2024 08:00AM

Sep 13, 2024 08:46AM Allarity Therapeutics (ALLR) Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 11, 2024 08:00AM

Aug 30, 2024 04:08PM

Jul 24, 2024 06:02AM

Jul 22, 2024 06:32AM

Jun 27, 2024 08:01AM

448,583 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All